← Back to Search

Other

Laser depilation for Pilonidal Disease

N/A
Waitlist Available
Led By Peter C Minneci, MD, MHSc
Research Sponsored by Nationwide Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is examining whether laser hair removal can help decrease the recurrence of pilonidal disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Recurrence of pilonidal disease
Secondary outcome measures
Disability Days
Health related quality of life

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Laser plus Standard of Care DepilationExperimental Treatment1 Intervention
Laser depilation to the natal cleft (pilonidal region) every 4-6 weeks for 5 treatments with either an 810nm or Nd:YAG laser dependent on Fitzpatrick skin type and tolerability. Patients and families in the intervention group will also be taught hair removal techniques and asked to perform either chemical or mechanical depilation as needed to keep the area hair-free between clinic treatments.
Group II: Standard of Care DepilationActive Control1 Intervention
Patients and families in the standard of care group will be taught hair removal techniques and asked to perform either chemical or mechanical depilation as needed to keep the area hair-free. Patients will be given supplies for six months of hair removal.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Laser depilation
2016
N/A
~20

Find a Location

Who is running the clinical trial?

Nationwide Children's HospitalLead Sponsor
341 Previous Clinical Trials
5,220,201 Total Patients Enrolled
Peter C Minneci, MD, MHScPrincipal InvestigatorNationwide Children's Hospital
Katherine J Deans, MD, MHScStudy DirectorNationwide Children's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being welcomed into this clinical experiment?

"This is evidenced by clinicaltrials.gov, the initial posting of this study was on September 5th 2017 and it has not been updated since July 22nd 2022. Consequently, no more patients are being enlisted into this trial; however, 4 additional trials are currently seeking participants for their respective studies."

Answered by AI

What criteria must individuals meet in order to participate in this trial?

"This clinical trial requires the recruitment of 302 participants between 11 to 21 years old that have been diagnosed with pilonidal disease and fit within all Fitzpatrick skin types."

Answered by AI

Does this research allow individuals above the age of 35 to participate?

"In accordance with the study's criteria, any potential participant must be between 11 and 21 years old."

Answered by AI
~40 spots leftby Apr 2025